SYP and Alzheimer disease: Based on our results, we speculate that the beneficial effects of phloroglucinol on AD behavioral phenotype is not due to a direct effect on generation and/or degradation of Aβ, but due to protective effects towards the reduction in dendritic spine density and synaptic proteins such as synaptophysin and PSD-95.